Novartis to Spend $70 Million More on R&D Each Month for Avidity
Novartis AG will spend as much as $70 million each month on research and development to advance Avidity…
Novartis Bolsters Immunology Pipeline With Excellergy Deal
Novartis NVS has announced the proposed acquisition of Excellergy Inc., reinforcing its strategic focus on expanding its immunology…